期刊文献+

脑梗死患者应用阿司匹林联合他汀类药物对颈动脉斑块的影响评价 被引量:31

The application of combing aspirin with statin to carotid plaques of cerebral infarction patients
下载PDF
导出
摘要 目的探讨脑梗死患者应用阿司匹林联合他汀类药物对颈动脉斑块的影响。方法选自2011年6月-2013年6月本院诊治伴颈动脉斑块的脑梗死患者68例,按随机数字表方法分成两组,每组34例,予阿司匹林作对照组,予阿司匹林联合他汀类药物作研究组,分析两组疗效、颈动脉内膜-中层厚度(IMT)及颈动脉的斑块面积情况。结果研究组有效率97.06%,比对照组82.35%高,差异具统计学意义(P<0.05);同时两组治疗后IMT和颈动脉斑块面积均比治疗前少,比较差异明显(P<0.05);且治疗后研究组IMT和颈动脉斑块面积比对照组少,比较差异具统计学意义(P<0.05)。结论对伴有颈动脉斑块的脑梗死患者予阿司匹林联合他汀类药,能明显提升患者疗效,并改善颈动脉斑块症状,具有一定临床应用和研究价值。 Objective To explore application of cerebral infarction patients using aspirin combined statin effects on carotid plaques.Methods we chose the data in June 2011-June 2013 in our hospital for treatment of 68 patients with cerebral infarction with carotid plaques,these were divided into two groups according to random number table method, each group were 34 cases,we used aspirin for control group,and used aspirin combined statin drugs for experiment team,we had analysis of two groups of curative effect,carotid intima-media thickness and carotid artery plaque area.Results The experiment team's effectiveness was 97.06%,were higher than the control group of 82.35%,There were statistical significance difference(P 〈 0.05);At the same time,the two groups after treatment of IMT and carotid plaque area were less than before treatment,compare the difference to be markedly (P 〈0.05);And after the treatment team IMT and carotid plaque area is less than the control group,There were statistical significance difference (P 〈0.05).Conclusion Cerebral infarction patients with carotid plaques were treated with aspirin combined statin drugs, patients could obviously improve,and improve the symptoms of carotid plaques,has certain clinical application and research value.
出处 《中国实验诊断学》 2014年第7期1087-1089,共3页 Chinese Journal of Laboratory Diagnosis
关键词 脑梗死 阿司匹林 他汀类药物 颈动脉斑块 Cerebral infarction Aspirin Statin Carotid plaques
  • 相关文献

参考文献6

  • 1Romano FA, Campo-Bustillo JG, Campo I, et al. High-dose atorv- astatin enhances impaired cerebral vasomotor reactivity[J]. Jour- nal of stroke and eerebrovascular diseases, 2012,24 (6) : 537.
  • 2Flynn RWV, MacDonald TM, Murray GD, et al. Persistence, ad- herence and outcome with antiplatelet regimens following cerebral infarction in the Tayside Stroke Cohort[J]. Cerebrovascular disea- ses,2012,30(2) :519.
  • 3Jiang Z. ,Sun J. ,Liang Q. ,et al. A metabonomic approach applied to predict patients with cerebral infarction[J]. Talanta, 2011,19 (2) : 374.
  • 4Zhang XM,Wang WJ, Yu YL, et al. BNP and NT-proBNP Assays for Heart-Failure Diagnosis in Patients With Cerebral Infarction[J]. Laboratory Medicine,2013,23(1) :672.
  • 5梁力晖.阿托伐他汀联合阿司匹林在预防老年脑梗死再发中的临床意义[J].中国医药导刊,2012,14(12):2152-2153. 被引量:10
  • 6陈军华,邓永胜,贺建中,汪雨珠,彭伏梅.阿司匹林联合他汀类药物预防脑梗死再发的临床观察[J].中华老年心脑血管病杂志,2010,12(12):1137-1137. 被引量:20

二级参考文献13

  • 1王新德.各类脑血管疾病诊断要点[J].中国乡村医药,1996,3(2):10-11. 被引量:216
  • 2王玉祥,李志群,孙向东.2型糖尿病合并脑梗死患者颈动脉、血脂及血浆纤维蛋白原的变化[J].临床神经病学杂志,2005,18(4):263-265. 被引量:11
  • 3Kadoglou NP, Gerasimidis T, Moumlzouoglou A, et al. Inten sive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. Eur J Vasc gndovasc Surg, 2008,35 : 661-668.
  • 4Uehara T, Tabuchi M, Mori E. Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia[J]. Stroke, 1999; 30(2):378-382.
  • 5Kobayashi S, Okada K, Koide H, et al. Subcortieal silent brain infarction as a risk factoi for clinical stroke[J]. Stroke, 1997; 28(10):1932-1939.
  • 6Ueno 1-1, Koyama H, Mima Y, et al. Comparison of the effect of cilostazol wit]'- aspirin on circulating endothelial progenitor cells and small-dense LDL cholesterol in diabetic patients with cerebral ischemia: a randomized controlled pilot trial[J] .J Atheroscler Thromb, 2011; 18( 10):883-890.
  • 7Calabro R S. Pezzini A, Gervasi G, et al. Recurrent ischemic stroke in a patient with ulcerative colitis and high levels of lipoprotein (a)[J]. Blood Coagul Fibrinolysis.2011 ;22(6):549-551.
  • 8Yamaguchi T, Hidaka N, Suemaru K, et al. The coadministration of paroxetine and low-dose aspirin synergistically enhances gastric ulcerogenic risk in rats[J]. Biol Pharm Bu11,2008;31(7): 1371-1375.
  • 9Bousser M G, Amareneo P, Chamorro A, et al. Rationale and design of a r-mdomixed, doL-bl-blind, parallel-group study of terutroban 30 rag/day versus aspirin I00 rag/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemie origin with terutroban in patients with a history of isehemic stroke or transient isehemic attack (PERFORM) study[J]. Cercbrovasc Dis,2009;27(5):509-518.
  • 10Bousser M G. Amarenco P, Chamorro A, et al. Terutroban versus aspirin in patients with cerebral isehaemie events (PERFORM): a randomised, double- blind, parallel-group trial[J]. Lancet,2011 ;377(9782):2013-2022.

共引文献25

同被引文献176

引证文献31

二级引证文献218

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部